LCN CONSULTING, INC.
(A boutique consulting firm specializing in investigating competitive intelligence in the pharmaceutical & biotechnology industries, serving mid-sized & Fortune 500 client accounts)
·Completing commission work on ad-hoc basis.
·A Fortune 100 client account was engaged in an internal debate on the choice of target customers & supporting trial designs of an in-licensed product undergoing Phase II development.The primary intelligence I gleaned from KOLs (key opinion leaders) on relevant disease state & patient pathways seriously challenged the prior beliefs of the project team.My research allowed the client to recalibrate target patient populations & supporting clinical trial end points.
·A mid-sized client account was conducting critical due diligence in assessing in-licensing a first-in-class compound to enrich its branded portfolio.The intelligence I distilled from primary & secondary investigations uncovered market opportunities as well as potential competing compounds unforeseen by the client.My research contributed to validating the client’s planned target while providing a clearer understanding of the target market to improve future planning.